DRUG PRICING & CHALLENGES TO HEPATITIS C TREATMENT ACCESS.

Clinical development success rates for investigational drugs

Michael Hay, David W. Thomas, John L. Craighead et al. · Nature Biotechnology · 2014 · 2.5K citations

Medicine, Clinical Pharmacy, Pharmacology +12

The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007

Kathleen N. Ly, Jian Xing, R. Monina Klevens et al. · Annals of Internal Medicine · 2012 · 715 citations

Public Health, Health Sciences, Epidemiologic Methods +16

A Decade of Direct-to-Consumer Advertising of Prescription Drugs

Julie M. Donohue, Marisa Cevasco, Meredith B. Rosenthal · New England Journal of Medicine · 2007 · 520 citations

Law, Marketing, Pharmaceutical Policy +17

The Anatomy of Medical Research

Hamilton Moses, David H. M. Matheson, Sarah Cairns‐Smith et al. · JAMA · 2015 · 442 citations

Public Affairs, Health Policy, Health Sciences +17

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

Soumitri Barua, Robert A. Greenwald, Jason Grebely et al. · Annals of Internal Medicine · 2015 · 397 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +17